CLINICAL ROLE -
Heart Attacks Linked to Low Phosphate Levels
Mid-range levels of phosphate in the blood may reduce the risk of heart attack.
Read More
Patients with High Breast Cancer Risk Not Receiving MRI Screening
Only 15% of patients with a 20% to 24% risk of breast cancer received a recommended MRI screening.
Large Number of Diabetic Foot Ulcers Result in Amputations
Less than half of diabetic foot ulcers heal within 1 year.
Regenerative Medicine Policy Issued by FDA
The FDA created a framework to create safe and effective regenerative medicine products.
Trending News Today: Many Americans Unaware of Affordable Care Act Open Enrollment
Top news of the day from across the healthcare landscape.
Trending News Today: CMS Seeks Guidance on Lowering Medicare Part D Costs
Sutent Receives FDA Approval for Renal Cell Carcinoma
Sunitinib malate (Sutent) is an adjuvant therapy for adults at risk of recurrent renal cell carcinoma following nephrectomy.
Adjuvant Renal Cell Carcinoma Drug Receives FDA Greenlight
Sunitinib malate (Sutent) may improve disease-free survival among patients with renal cell carcinoma.
Hemlibra Gets FDA Approval to Treat Hemophilia A
Emicizumab-kxwh is administered as a weekly subcutaneous injection to restore clotting ability in patients with hemophilia.
FDA Approves Prophylactic Hemophilia Drug to Prevent Bleeding
Emicizumab-kxwh (Hemlibra) demonstrated the ability to reduce bleeding events that require treatment in patients with hemophilia A.
FDA Expands Indication for Fulvestrant Combination to HR+/HER2- Breast Cancer
Fulvestrant (Faslodex) plus abemaciclib may improve progression-free survival among patients with advanced or metastatic breast cancer.
FDA Approves Biologic Drug for Eosinophilic Asthma
Benralizumab is a monoclonal antibody that causes natural killer immune cells to reduce eosinophils.
Biologic Drug Receives Approval for Eosinophilic Asthma
Benralizumab (Fasenra) demonstrates the ability to significantly deplete eosinophils and could reduce the need for oral steroid use.
FDA Authorizes Device for Opioid Withdrawal Treatment
The NSS-2 Bridge device reduced opioid withdrawal symptoms more than 31% within 30 minutes of treatment.
FDA Warns Gout Drug May Increase Cardiovascular Death
Febuxostat (Uloric) could escalate heart-related and all-cause mortality.
Fallopian Tube Mutation Could Lead to Early Diagnosis of Ovarian Cancer
Fallopian tube lesions may be the precursor to high-grade serious ovarian carcinoma.
Mutation That Reduced Efficacy of 2016/2017 Flu Vaccine Discovered
The 2016/2017 H3N2 influenza vaccine was only 30% effective, leaving many vulnerable to infection.
Trending News Today: House Approves Defense Bill that Expedites Military Drug Approvals
Trending News Today: ACA Sign Ups Far Outpace 2017 Enrollment
FDA Approves Drug for Rare Inherited Genetic Condition
Vestronidase alfa-vjbk (Mepsevii) approved mucopolysaccharidosis type VII, an extremely rare metabolic condition is also known as Sly syndrome.
Orphan Drug Gets FDA Nod for Genetic Enzyme Disease
Vestronidase alfa-vjbk (Mepsevii) approved to treat mucopolysaccharidosis.
Switching Studies Show Efficacy of Multiple Sandoz Biosimilars
The efficacy and safety of an adalimumab biosimilar matched the reference products in switching studies treating plaque psoriasis and rheumatoid arthritis.
Diverse Clinical Trials Necessary for Better Treatments
Study finds that most clinical trials lack diversity, which could affect known treatment responses.
Breast Cancer Cells Use Byproducts for Tumor Growth
Exposure to ammonia found to amplify breast cancer cell proliferation.
Genetic Factors Link Common Allergic Conditions
The same genes may influence asthma, hay fever, and eczema risk.
High Intensity Physical Activity Could Reduce Mortality Risk Among Women
Mortality risk may be significantly lowered among older women who participate in moderate to vigorous physical activity.
Millions Gain Access to Treatment for Hepatitis C Virus
Significant gains have been made against viral hepatitis.
Trending News Today: Tax Reform Legislation Will Include ACA Individual Mandate Repeal
Trending News Today: Researchers Take a New Approach to Gene Therapy
Jardiance Reduces Mortality Risk for Patients with Diabetes
Empagliflozin (Jardiance) reduced the risk of cardiovascular mortality by 43% in patients with type 2 diabetes and peripheral artery disease.